Big Move For Iterum Therapeutics plc
Tue, Dec 10, 2019 at 05:30 PM
Iterum Therapeutics plc (ITRM:NASDAQ) rocketted at $4.85, representing a gain of 21.9%. On Mon 09 Dec 19, ITRM:NASDAQ hit a New 2-Week High of $3.98. The stock appeared on our News Catalysts scanner on Tue 10 Dec 19 at 05:28 PM in the 'BIOTECH' category. From Mon 18 Nov 19, the stock recorded 57.14% Up Days and 60.00% Green Days
About Iterum Therapeutics plc (ITRM:NASDAQ)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Top 10 Gainers:
- Technical Communications Corporation (TCCO:NASDAQ), 321.05%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 75.54%
- Venus Concept Inc. (VERO:NASDAQ), 74.83%
- Camber Energy, Inc. (CEI:NYSEMKT), 68.06%
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 44.62%
- Neoleukin Therapeutics, Inc. (NLTX:NASDAQ), 26.75%
- Edison Nation, Inc. (EDNT:NASDAQ), 22.3%
- Iterum Therapeutics plc (ITRM:NASDAQ), 21.86%
- Pintec Technology Holdings Limited (PT:NASDAQ), 19.54%
- QuickLogic Corporation (QUIK:NASDAQ), 18.18%